Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | CALM1 | P0DP23 | 3/20 | 0.52 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
| ▸ | DAO | P14920 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.42 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.42 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13980912 | 0.89 | PTGS2 (0.50) | CYP19A1ALDH1A1PTGS2CALM1AKR1B1 | |
| SCHEMBL9491787 | 0.87 | CYP19A1 (0.68) | CYP19A1ALDH1A1PTGS2CALM1AKR1B1 | |
| SCHEMBL13369436 | 0.87 | PTGS2 (0.49) | CYP19A1ALDH1A1PTGS2CALM1AKR1B1 | |
| SCHEMBL9279920 | 0.86 | PTGS2 (0.67) | CYP19A1ALDH1A1PTGS2CALM1AKR1B1 | |
| SCHEMBL16951830 | 0.85 | DAO (0.53) | CYP19A1ALDH1A1PTGS2CALM1AKR1B1 | |
| SCHEMBL16956526 | 0.85 | PTGS2 (0.47) | CYP19A1ALDH1A1PTGS2CALM1AKR1B1 | |
| SCHEMBL14288599 | 0.85 | PTGS2 (0.47) | CYP19A1ALDH1A1PTGS2CALM1AKR1B1 | |
| SCHEMBL13548286 | 0.85 | PTGS2 (0.47) | CYP19A1ALDH1A1PTGS2CALM1AKR1B1 | |
| SCHEMBL20098971 | 0.85 | CYP19A1 (0.56) | CYP19A1ALDH1A1PTGS2CALM1AKR1B1 | |
| SCHEMBL30195497 | 0.85 | PTGS2 (0.77) | CYP19A1PTGS2CALM1AKR1B1GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4711359-A2 | RESCORCINOLS, METHODS FOR THEIR MANUFACTURE, AND USES THEREOF | Jazz Pharmaceuticals Research UK Limited (GB) | 2026-03-18 | — | — | EP | disclosed |
| EP-4709724-A1 | ANTICONVULSIVE COMPOUNDS AND USES THEREOF | Jazz Pharmaceuticals Research UK Limited (GB) | 2026-03-18 | — | — | EP | disclosed |
| WO-2025078811-A1 | CANNABINOID COMPOUNDS AND USES THEREOF | JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (GB) | 2025-04-17 | — | — | WO | disclosed |
| EP-3722276-B1 | PROCESS FOR THE PRODUCTION OF PURIFIED CANNABIDIOL | PURISYS LLC (US) | 2025-01-08 | — | — | EP | disclosed |
| CN-113905730-B | Solid compositions of cannabinoid co-crystals | 南迪亚公司 | 2025-01-03 | — | — | CN | disclosed |
| WO-2024236275-A1 | ANTICONVULSIVE COMPOUNDS AND USES THEREOF | JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (GB) | 2024-11-21 | — | — | WO | disclosed |
| US-20240254066-A1 | RESCORCINOLS, METHODS FOR THEIR MANUFACTURE, AND USES THEREOF | JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (GB) | 2024-08-01 | — | — | US | disclosed |
| US-11993563-B2 | Solid compositions of cocrystals of cannabinoids | ENANTIA S.L. (ES) | 2024-05-28 | — | — | US | disclosed |
| CN-117396455-A | Resorcinol, its manufacturing method and use | 吉伟研究有限公司 | 2024-01-12 | — | — | CN | disclosed |
| US-20230203096-A1 | EPHA4 TARGETING COMPOUNDS AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-06-29 | — | — | US | disclosed |
| EP-1049662-A1 | INHIBITORS OF ALPHA4 MEDIATED CELL ADHESION | TANABE SEIYAKU CO., LTD. (JP) | 2000-11-08 | — | — | EP | disclosed |
| WO-2000041505-A2 | ANTHRANILIC ACID DERIVATIVES | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000042003-A1 | BENZENESULFONAMIDE DERIVATIVES AND THEIR USE AS MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000042029-A1 | 1-HETEROCYCLE SUBSTITUTED DIARYLAMINES | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000041994-A1 | 4-ARYLAMINO, 4-ARYLOXY, AND 4-ARYLTHIO DIARYLAMINES AND DERIVATIVES THEREOF AS SELECTIVE MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000042022-A1 | BENZOHETEROCYCLES AND THEIR USE AS MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000042002-A1 | SULPHOHYDROXAMIC ACIDS AND SULPHOHYDROXAMATES AND THEIR USE AS MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-1999036393-A1 | INHIBITORS OF α4 MEDIATED CELL ADHESION | TANABE SEIYAKU CO., LTD. (JP) | 1999-07-22 | — | — | WO | disclosed |
| WO-1998008837-A1 | PHENYLBUTANOL DERIVATIVES, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF | FARMACON, INC. (US) | 1998-03-05 | — | — | WO | disclosed |
| US-5399785-A | Applying methylenebis/2,4-dihydroxybenzene/ derivatives; cosmetics | NIPPON PAINT CO., LTD. (JP) | 1995-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203096-A1 | EPHA4 TARGETING COMPOUNDS AND METHODS OF USE THEREOF | EPHA4, EPHA1, EPHA5 | CYP19A1 1213/4885ALDH1A1 1458/4885PTGS2 4009/4885 |
| US-11993563-B2 | Solid compositions of cocrystals of cannabinoids | CNR1, CNR2, FAAH | CYP19A1 227/4885ALDH1A1 1780/4885PTGS2 2547/4885 |
| US-20240254066-A1 | RESCORCINOLS, METHODS FOR THEIR MANUFACTURE, AND USES THEREOF | REN, CYP46A1, NQO1 | CYP19A1 257/4885ALDH1A1 796/4885PTGS2 1616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.